Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Yi, J; Clarke, JM; Healy, P; Wang, XF; Shoemaker, D; Onaitis, MW; Dumbauld, C; Osborne, R; Crawford, J; Harpole, D; D'Amico, TA; Dunphy, F; Christensen, J; Ready, N; Weinhold, K

Published Date

  • March 1, 2017

Published In

Volume / Issue

  • 35 / 7

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET

Conference Location

  • Chicago, IL

Conference Start Date

  • June 2, 2017

Conference End Date

  • June 7, 2017